• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决漏管问题:如何提高基于患者报告结局的预后和预测模型在癌症临床实践中的应用。

Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.

机构信息

Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.

Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

出版信息

JCO Clin Cancer Inform. 2023 Sep;7:e2300070. doi: 10.1200/CCI.23.00070.

DOI:10.1200/CCI.23.00070
PMID:37976441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10681558/
Abstract

PURPOSE

This discussion paper outlines challenges and proposes solutions for successfully implementing prediction models that incorporate patient-reported outcomes (PROs) in cancer practice.

METHODS

We organized a full-day multidisciplinary meeting of people with expertise in cancer care delivery, PRO collection, PRO use in prediction modeling, computing, implementation, and decision science. The discussions presented here focused on identifying challenges to the development, implementation and use of prediction models incorporating PROs, and suggesting possible solutions.

RESULTS

Specific challenges and solutions were identified across three broad areas. (1) Understanding decision making and implementation: necessitating multidisciplinary collaboration in the early stages and throughout; early stakeholder engagement to define the decision problem and ensure acceptability of PROs in prediction; understanding patient/clinician interpretation of PRO predictions and uncertainty to optimize prediction impact; striving for model integration into existing electronic health records; and early regulatory alignment. (2) Recognizing the limitations to PRO collection and their impact on prediction: incorporating validated, clinically important PROs to maximize model generalizability and clinical engagement; and minimizing missing PRO data (resulting from both structural digital exclusion and time-varying factors) to avoid exacerbating existing inequalities. (3) Statistical and modeling challenges: incorporating statistical methods to address missing data; ensuring predictive modeling recognizes complex causal relationships; and considering temporal and geographic recalibration so that model predictions reflect the relevant population.

CONCLUSION

Developing and implementing PRO-based prediction models in cancer care requires extensive multidisciplinary working from the earliest stages, recognition of implementation challenges because of PRO collection and model presentation, and robust statistical methods to manage missing data, causality, and calibration. Prediction models incorporating PROs should be viewed as complex interventions, with their development and impact assessment carried out to reflect this.

摘要

目的

本讨论文件概述了在癌症实践中成功实施纳入患者报告结局(PROs)的预测模型所面临的挑战,并提出了相应的解决方案。

方法

我们组织了一次为期一整天的多学科会议,参会人员均为癌症护理提供、PRO 收集、PRO 在预测模型中应用、计算、实施和决策科学等方面的专家。本文讨论的重点是确定纳入 PRO 的预测模型在开发、实施和应用中所面临的挑战,并提出可能的解决方案。

结果

在三个广泛的领域中确定了具体的挑战和解决方案。(1)理解决策制定和实施:需要在早期阶段以及整个过程中进行多学科合作;早期利益相关者参与,以定义决策问题并确保 PRO 在预测中的可接受性;了解患者/临床医生对 PRO 预测和不确定性的解释,以优化预测效果;努力将模型整合到现有的电子健康记录中;并尽早与监管机构达成一致。(2)认识到 PRO 收集的局限性及其对预测的影响:纳入经过验证的、具有临床重要性的 PRO,以最大限度地提高模型的通用性和临床参与度;并尽量减少 PRO 数据的缺失(由于结构性数字排除和时变因素导致),以避免加剧现有的不平等。(3)统计和建模挑战:纳入统计方法来解决缺失数据问题;确保预测建模能够识别复杂的因果关系;并考虑时间和地理重新校准,以使模型预测反映相关人群。

结论

在癌症护理中开发和实施基于 PRO 的预测模型需要从早期阶段就进行广泛的多学科合作,认识到由于 PRO 收集和模型呈现而带来的实施挑战,以及采用稳健的统计方法来处理缺失数据、因果关系和校准问题。纳入 PRO 的预测模型应被视为复杂干预措施,其开发和影响评估应反映这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c46/10681558/74908805d464/cci-7-e2300070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c46/10681558/0750852f3228/cci-7-e2300070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c46/10681558/74908805d464/cci-7-e2300070-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c46/10681558/0750852f3228/cci-7-e2300070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c46/10681558/74908805d464/cci-7-e2300070-g002.jpg

相似文献

1
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.解决漏管问题:如何提高基于患者报告结局的预后和预测模型在癌症临床实践中的应用。
JCO Clin Cancer Inform. 2023 Sep;7:e2300070. doi: 10.1200/CCI.23.00070.
2
Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies.利用利益相关者参与克服癌症护理提供中实施患者报告结局(PROs)的障碍:来自 3 项前瞻性研究的方法。
Med Care. 2019 May;57 Suppl 5 Suppl 1:S92-S99. doi: 10.1097/MLR.0000000000001103.
3
Use of Patient-Reported Outcomes in Risk Prediction Model Development to Support Cancer Care Delivery: A Scoping Review.使用患者报告结局在风险预测模型开发中支持癌症护理提供:范围综述。
JCO Clin Cancer Inform. 2024 Nov;8:e2400145. doi: 10.1200/CCI-24-00145. Epub 2024 Nov 1.
4
eSyM: An Electronic Health Record-Integrated Patient-Reported Outcomes-Based Cancer Symptom Management Program Used by Six Diverse Health Systems.eSyM:一个电子健康记录集成的基于患者报告的癌症症状管理方案,被六个不同的医疗系统使用。
JCO Clin Cancer Inform. 2022 Jan;6:e2100137. doi: 10.1200/CCI.21.00137.
5
Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology.推进患者报告结局在实践中的应用:了解挑战、机遇和健康信息技术的潜力。
Qual Life Res. 2019 Jun;28(6):1575-1583. doi: 10.1007/s11136-019-02112-0. Epub 2019 Jan 25.
6
Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials.将患者声音纳入癌症临床试验中患者报告结局的制定和实施中。
Health Expect. 2020 Feb;23(1):41-51. doi: 10.1111/hex.12997. Epub 2019 Nov 13.
7
Improving Cancer Care Through the Patient Experience: How to Use Patient-Reported Outcomes in Clinical Practice.通过患者体验改善癌症护理:如何在临床实践中使用患者报告的结果。
Am Soc Clin Oncol Educ Book. 2017;37:695-704. doi: 10.1200/EDBK_175418.
8
AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes.AMCP 合作论坛:利用患者报告的结局改善质量、价值和结果。
J Manag Care Spec Pharm. 2018 Mar;24(3):304-310. doi: 10.18553/jmcp.2018.17491. Epub 2018 Feb 20.
9
10
Oh, the Places We'll Go: Patient-Reported Outcomes and Electronic Health Records.哦,我们将去的地方:患者报告的结果和电子健康记录。
Patient. 2018 Dec;11(6):591-598. doi: 10.1007/s40271-018-0321-9.

引用本文的文献

1
Meaningful differences in patient-reported outcome measurement scores in liver disease.肝病患者报告结局测量分数的显著差异。
Hepatol Commun. 2025 May 29;9(6). doi: 10.1097/HC9.0000000000000727. eCollection 2025 Jun 1.
2
The Role of Patient-Reported Outcomes in Cirrhosis.患者报告结局在肝硬化中的作用。
Am J Gastroenterol. 2025 May 20;120(8):1708-1719. doi: 10.14309/ajg.0000000000003551.
3
PRO-Based Stratification Improves Model Prediction for Toxicity and Survival of Head and Neck Cancer Patients.基于PRO的分层改善了头颈部癌患者毒性和生存的模型预测。

本文引用的文献

1
Lessons learnt for digital inclusion in underserved communities from implementing a covid virtual ward.通过实施新冠虚拟病房,在服务不足社区实现数字包容的经验教训。
PLOS Digit Health. 2022 Nov 16;1(11):e0000146. doi: 10.1371/journal.pdig.0000146. eCollection 2022 Nov.
2
Measures used to assess interventions for increasing patient involvement in Danish healthcare setting: a rapid review.评估干预措施以增加丹麦医疗保健环境中患者参与度的方法:快速综述。
BMJ Open. 2022 Dec 26;12(12):e064067. doi: 10.1136/bmjopen-2022-064067.
3
Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models.
IEEE J Biomed Health Inform. 2025 Feb;29(2):807-814. doi: 10.1109/JBHI.2024.3515092. Epub 2025 Feb 10.
4
Exploring the value of routinely collected data on EQ-5D-5L and other electronic patient-reported outcome measures as prognostic factors in adults with advanced non-small cell lung cancer receiving immunotherapy.探索常规收集的EQ-5D-5L数据及其他电子患者报告结局指标作为接受免疫治疗的晚期非小细胞肺癌成年患者预后因素的价值。
BMJ Oncol. 2024 May 15;3(1):e000158. doi: 10.1136/bmjonc-2023-000158. eCollection 2024.
5
The Hallmarks of Predictive Oncology.预测性肿瘤学的特征。
Cancer Discov. 2025 Feb 7;15(2):271-285. doi: 10.1158/2159-8290.CD-24-0760.
6
Developing feasible and acceptable strategies for integrating the use of patient-reported outcome measures (PROMs) in gender-affirming care: An implementation study.制定切实可行且可接受的策略,将患者报告结局测量(PROMs)整合到性别肯定护理中:一项实施研究。
PLoS One. 2024 Apr 16;19(4):e0301922. doi: 10.1371/journal.pone.0301922. eCollection 2024.
评估生存结局预测模型的性能和临床实用性:Cox 比例风险模型的实用指南。
Ann Intern Med. 2023 Jan;176(1):105-114. doi: 10.7326/M22-0844. Epub 2022 Dec 27.
4
A systematic review of patient-reported outcome measures for advanced skin cancer patients.晚期皮肤癌患者报告结局测量的系统评价。
Arch Dermatol Res. 2023 Aug;315(6):1473-1480. doi: 10.1007/s00403-022-02479-0. Epub 2022 Dec 5.
5
Patient reported outcome measure domains and tools used among adolescents and young adults with cancer: A scoping review.癌症青少年和青年患者报告的结局测量领域及使用的工具:一项范围综述
Crit Rev Oncol Hematol. 2023 Jan;181:103867. doi: 10.1016/j.critrevonc.2022.103867. Epub 2022 Nov 22.
6
Prognostic value of patient-reported outcome measures (PROMs) in adults with non-small cell Lung Cancer: a scoping review.患者报告结局测量(PROMs)在成人非小细胞肺癌中的预后价值:系统评价。
BMC Cancer. 2022 Oct 19;22(1):1076. doi: 10.1186/s12885-022-10151-z.
7
Replacing performance status with a simple patient-reported outcome in palliative radiotherapy prognostic modelling.在姑息性放疗预后模型中用简单的患者报告结局取代性能状态。
Clin Transl Radiat Oncol. 2022 Oct 3;37:137-144. doi: 10.1016/j.ctro.2022.09.008. eCollection 2022 Nov.
8
Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection.减少或解决患者报告结局(PRO)数据收集过程中受访者负担的关键考虑因素。
Nat Commun. 2022 Oct 12;13(1):6026. doi: 10.1038/s41467-022-33826-4.
9
Developing, validating, updating and judging the impact of prognostic models for respiratory diseases.开发、验证、更新和评判呼吸系统疾病预后模型的影响。
Eur Respir J. 2022 Sep 15;60(3). doi: 10.1183/13993003.00250-2022. Print 2022 Sep.
10
Agreement between older adult patient and caregiver proxy symptom reports.老年患者与照顾者代理症状报告之间的一致性。
J Patient Rep Outcomes. 2022 May 14;6(1):50. doi: 10.1186/s41687-022-00457-8.